Johnson Fistel, PLLC is investigating potential securities fraud claims on behalf of investors in Lumexa Imaging Holdings, On Holding AG, and MillerKnoll. The investigations were prompted by significant stock price declines following financial disclosures on March 26, 2026. Investors who suffered losses are encouraged to contact the firm.

Johnson Fistel, PLLC is investigating potential securities fraud claims on behalf of investors in On Holding AG, Lumexa Imaging Holdings, and MillerKnoll. The investigation into On Holding was triggered by a March 25, 2026 announcement of organizational restructuring, including the appointment of co-founders as Co-CEOs and the stepping down of the current CEO, which resulted in a stock price decline.

U.S. stock futures fell on Thursday amid escalating Iran tensions and Trump's threats of military action. Major indices declined with the Dow down 0.47%, S&P 500 down 0.55%, and Nasdaq 100 down 0.65%. BlackRock downgraded U.S. stocks to neutral citing geopolitical risks and energy market disruptions. Several individual stocks experienced significant moves: Olaplex surged 48% on acquisition news, while Worthington Steel plunged 14% and MillerKnoll dropped 19% on weak earnings.

The global educational furniture market is expected to grow at a CAGR of 5.23% from 2025 to 2030, driven by factors like rising enrollment rates, increased disposable income, and government initiatives to enhance educational infrastructure. The market is fragmented, with large players dominating in developed economies and regional players in developing markets.

Virco Manufacturing Corporation reported better-than-expected Q2 earnings, beating the Zacks Consensus Estimate. The company's revenues, however, missed the consensus estimate. The stock has outperformed the S&P 500 so far this year.

American Outdoor's (AOUT) fiscal fourth-quarter 2024 results reflect top-line growth on the back of demand strength in its outdoor lifestyle and shooting sports categories. However, increased costs and expenses hurt the bottom line.

CULP's fourth-quarter fiscal 2024 results reflect ongoing macroeconomic headwinds impacting the sales trend of the company across its two reportable businesses. Yet, operational excellence and restructuring initiatives bode well.

MillerKnoll's (MLKN) fourth-quarter fiscal 2024 results reflect the notable performance of the International Contract and Specialty segment. Also, price realizations, cost synergies, and channel optimization strategies aided the bottom line.

MillerKnoll (MLKN) delivered earnings and revenue surprises of 26.42% and 1.13%, respectively, for the quarter ended May 2024. Do the numbers hold clues to what lies ahead for the stock?

MillerKnoll's (MLKN) fiscal fourth-quarter results are likely to ail from lower sales volume and challenging macroeconomic conditions across the globe.

La-Z-Boy (LZB) delivered earnings and revenue surprises of 39.71% and 6.70%, respectively, for the quarter ended April 2024. Do the numbers hold clues to what lies ahead for the stock?

Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-expected fourth-quarter loss. Kodiak Sciences posted a quarterly loss of $1.13 per share, compared to market expectations for a loss of 77 cents per share. Kodiak Sciences shares dipped 19.9% to $5.97 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares jumped 430% to $25.35 after the company announced it acquired a Phase 2-ready anti-IL-1β mAb, which it refers to as AVTX-009, through the acquisition of privately held AlmataBio. The company also announced a private placement financing of up to $185 million. Xilio Therapeutics, Inc. (NASDAQ: XLO) gained 146% to $1.58 after the company announced an exclusive license agreement with Gilead Sciences for a tumor-activated IL-12 program. The company announced a $11.3 million private placement equity financing. Biodexa Pharmaceuticals Plc (NASDAQ: BDRX) shares climbed 80% to $1.5395. Biodexa's MTX110 showed promise in extending life expectancy against aggressive brain cancers. Ontrak, Inc. (NASDAQ: OTRK) gained 55% to $0.9239. Binah Capital Group, Inc. (NASDAQ: BCG) gained 48% to $14.05 after dipping more than 20% on Wednesday. Kidpik Corp. (NASDAQ: PIK) gained 40.7% to $4.5999. Kidpik recently regained compliance with the Nasdaq minimum bid price requirement. Allego N.V. (NASDAQ: ALLG) rose 32.8% to $1.7650. Akanda Corp. (NASDAQ: AKAN) gained 28% to $0.2053 after the company announced a plan to evaluate opportunities in Bitcoin, Blockchain and AI applications in the cannabis industry. Destiny Tech100 Inc. (NASDAQ: DXYZ) rose 26% to $22.15. REX American Resources Corporation (NYSE: REX) gained 23.2% to $54.15 following upbeat earnings. Nutriband Inc. (NASDAQ: NTRB) gained 23% to $4.98. Nutriband recently provided a clinical and regulatory path overview for its AVERSA Fentanyl patch. Summit Therapeutics Inc. (NASDAQ: ...